文献速递传染病防控与疫情报告免疫规划

牛对钩端螺旋体抗原在不同新型佐剂与疫苗递送平台中的免疫应答

Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.
PubMed 文献 · Vaccine · 2020-03-20

本研究将问号钩端螺旋体博格彼得森尼血清型Hardjo株203抗原与新型佐剂(可生物降解聚酸酐压缩棒植入物VPEAR、聚二氨基硫化物微粒PNSN-MP、水包油包水乳剂佐剂、氢氧化铝)组合,在牛中间隔4周免疫两次,并与商业单价钩端螺旋体疫苗Spirovac比较免疫应答。结果显示含钩端螺旋体抗原加水包油乳剂、PNSN-MP或氢氧化铝的组及Spirovac组在免疫后8周和20周血清抗体应答增加(P>0.05),以IgG1为主;VPEAR组初次免疫后未检测到抗原特异性免疫应答,但在抗原回忆应答中检测到。

要点

  • 含钩端螺旋体抗原加水包油乳剂、PNSN-MP或氢氧化铝的组及Spirovac组在免疫后8周和20周血清抗体应答增加(P>0.05)。
  • VPEAR组初次免疫后未检测到抗原特异性免疫应答,但在抗原回忆应答中检测到。
  • Spirovac、油水油或PNSN-MP组牛的外周血单核细胞在体外钩端螺旋体抗原刺激后IL-17A释放增加(P<0.05)。

核心结论

  • 数据表明将钩端螺旋体抗原与这些佐剂组合可增强牛的免疫原性。
  • 数据提示含可生物降解聚合物微粒和油乳剂佐剂的疫苗诱导的免疫应答与商业疫苗相似或更强。
  • 数据提示这些新疫苗配方值得进一步研究作为牛及其他家畜的新疫苗配方。

研究设计与样本

  • 牛间隔4周免疫两次,接种仅含佐剂或含钩端螺旋体抗原的制剂,并与接种商业单价钩端螺旋体疫苗Spirovac的牛比较免疫应答。
  • 所有动物在第20周接种单剂Spirovac以评估抗原回忆应答。

主要发现

  • 含钩端螺旋体抗原加水包油乳剂、PNSN-MP或氢氧化铝的组及Spirovac组在免疫后8周和20周血清抗体应答增加(P>0.05)。
  • 体液应答以IgG1同型为主。
  • Spirovac、PNSN-MP和水包油包水处理组在初次免疫后检测到抗原特异性增殖应答。
  • 多数增殖应答发生在表达CD45RO和CD25标志物的CD4+和γδ T细胞群中,与效应记忆表型一致。
  • VPEAR组初次接种后未检测到抗原特异性免疫应答,但在抗原回忆应答中检测到。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Leptospirosis is a global zoonosis causing significant economic losses for cattle production. Current cattle vaccines against leptospirosis need improvement to provide efficacy against multiple serovars, reduce shedding in urine, and to induce earlier and more robust immune responses. In this study, Leptospira borgpetersenii serovar Hardjo strain 203 antigen was combined with novel adjuvants (a biodegradable polyanhydride compressed rod implant (VPEAR), poly(diaminosulfide) microparticles, a water-oil-water emulsion adjuvant, and aluminum hydroxide) to develop novel vaccines. Cattle were immunized twice, at a 4 week interval, with inoculums containing adjuvants alone or leptospira antigens and immune responses were compared to responses of cattle receiving a commercial monovalent leptospirosis vaccine (Spirovac). All animals were inoculated with a single dose of Spirovac at 20 weeks to assess antigen recall responses. Serum antibody responses were increased (P > 0.05) at 8 and 20 weeks after vaccination in cattle receiving inoculums containing leptospira antigens combined with water-oil-emulsion, poly(diaminosulfide) microparticles (PNSN-MP), or aluminum hydroxide and in cattle vaccinated with Spirovac. Humoral responses were predominantly IgG1 isotypes. Antigen-specific proliferative responses were detected after initial vaccination in cattle vaccinated with Spirovac, PNSN-MP and water-oil-water treatments. Most proliferative responses occurring within CD4+ and gamma delta T cell populations expressing CD45RO and CD25 markers, a response consistent with an effector memory phenotype. Antigen-specific immune responses were not detected in cattle vaccinated with VPEAR after initial inoculation, but were detected in the antigen recall responses. PBMCs from cattle vaccinated with Spirovac, oil-water-oil, or PNSN-MP treatments had increased (P < 0.05) IL-17A release after in vitro stimulation with leptospirosis antigens, whereas all groups produced IFN-γ and IL-17A after in vitro stimulation during the antigen recall response. Our data demonstrates that combining leptospirosis antigens with these adjuvants enhances immunogenicity in cattle. Interpretative Summary: Vaccination of livestock is a key mechanism for minimizing transmission of leptospirosis, a zoonotic disease. Leptospirosis vaccines for cattle need to be improved to provide greater levels of protection from kidney colonization, better immune responses, and protection against multiple serovars. This could be accomplished using new vaccine adjuvants. In this study, several novel adjuvants were evaluated for their ability to induce effective immune responses in cattle to leptospira antigens as compared to currently available vaccines. Data suggested that vaccines containing biodegradable polymer microparticles and oil-emulsion adjuvants induced similar or greater immune responses as compared to a commercial vaccine. Our data suggest these new vaccine formulations warrant further investigation as new vaccine formulations for cattle and other livestock.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wilson-Welder JH, Boggiatto P, Nally JE, et al. Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms. Vaccine. 2020. PMID: 32204939. doi:10.1016/j.vaccine.2020.02.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。